Faeth Therapeutics, Inc.

FTH·NasdaqCM·Healthcare
Compare
19.99+0.34 (+1.73%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close19.65
Open20.34
Day range19.0820.44
52-week range7.4542.14
Off day high−2.20%
Off 52-week high−52.57%
Volume236.01K
Avg. volume (3M)366.52K
Market cap516.62M
EPS (TTM)-22.50
Forward P/E-5.45
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.18
Shares outstanding25.84M
Short interest9.12% of float
Earnings dateNov 3, 2026
Analyst target55.38
Profit margin0.00%

Against its peers

Compare in full ›
FTH ARCT AVBP AKTS AGEN OBX
Market cap 516.62M 308.96M 665.16M 845.42M 314.78M 678.88M
P/E (TTM) — — — — 2.8 —
Forward P/E -5.4 -2.9 -3.6 -7.1 -63.4 -5.2
Price/book 1.4 1.8 1.8 1.7 -1.5 -0.8
Dividend yield — — — — — —
1-year change +121.53% +10.42% −28.97% −33.30% +81.51% −24.40%
Today +1.73% +13.94% +3.61% +1.74% +4.50% −16.93%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Faeth Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Arcturus Therapeutics Holdings Inc.ARCT · Biotechnology 308.96M 10.87 +13.94%
ArriVent BioPharma, Inc.AVBP · Biotechnology 665.16M 13.49 +3.61%
Aktis Oncology, Inc.AKTS · Biotechnology 845.42M 15.20 +1.74%
Agenus Inc.AGEN · Biotechnology 314.78M 6.97 +4.50%
Obsidian Therapeutics, Inc.OBX · Biotechnology 678.88M 10.99 −16.93%
Coherus Oncology, Inc.CHRS · Biotechnology 131.36M 0.8502 +5.54%
Nektar TherapeuticsNKTR · Biotechnology 1.31B 38.48 +1.91%
Janux Therapeutics, Inc.JANX · Biotechnology 1.11B 18.18 +2.02%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Gyre Therapeutics, Inc.GYRE · San Diego, CA 470.79M 4.4400 0.00%
Oculis Holding AGOCS · Zug, Switzerland 448.36M 7.28 −4.59%
Monopar Therapeutics Inc.MNPR · Wilmette, IL 488.71M 72.81 +4.18%
FluoGuide A/SFLUO.ST · Copenhagen, Denmark 493.75M 30.20 +0.33%
Surrozen, Inc.SRZN · South San Francisco, CA 553.72M 31.65 +5.08%
DiaMedica Therapeutics Inc.DMAC · Minneapolis, MN 580.78M 10.77 +7.70%
REGENXBIO Inc.RGNX · Rockville, MD 508.96M 7.71 +1.05%
Crescent Biopharma, Inc.CBIO · Waltham, MA 513.37M 13.82 +5.82%

Also based in Rockville, Maryland, then elsewhere in Maryland.

Company Mkt cap Price Today
X-Energy, Inc.XE · Rockville, MDOdds 4.08B 10.05 −8.47%
Supernus Pharmaceuticals, Inc.SUPN · Rockville, MD 1.64B 28.21 +0.21%
CEVA, Inc.CEVA · Rockville, MD 788.88M 28.02 −4.17%
Capital Bancorp, Inc.CBNK · Rockville, MD 714.87M 43.78 +2.70%
REGENXBIO Inc.RGNX · Rockville, MD 508.96M 7.71 +1.05%
MaxCyte, Inc.MXCT · Rockville, MD 143.46M 1.3900 −4.79%
MacroGenics, Inc.MGNX · Rockville, MD 147.15M 2.3100 −0.86%
NovaBridge BiosciencesNBP · Rockville, MD 117.16M 1.0100 0.00%

The stocks whose daily moves over the past year went most closely with Faeth Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Aktis Oncology, Inc.AKTS · Correlation 0.31 845.42M 15.20 +1.74%

What visitors to Faeth Therapeutics's page also look at.

Company Mkt cap Price Today
Surrozen, Inc.SRZN 553.72M 31.65 +5.08%
Werewolf Therapeutics, Inc.HOWL 52.98M 1.0900 +1.87%
Vor Biopharma Inc.VOR 1.24B 20.12 +1.31%
Instil Bio, Inc.TIL 47.41M 6.99 +4.80%
IN8bio, Inc.INAB 9.18M 0.9307 −2.02%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All FTH news ›
MarketScreener·Positive

Faeth Therapeutics, Inc. Announces Management Changes

Faeth Therapeutics, Inc. announced the appointments of Deepak Tiwari as Senior Vice President, Technical Operations, and Matt Biegler as Senior Vice President, Investor Relations, as the company... announced the appointments of Deepak…

FTREFTHYMAT
MarketScreener·Positive

Raymond James Initiates Faeth Therapeutics at Outperform

Faeth Therapeutics has an average rating of buy and mean price target of $54.88, according to analysts polled by FactSet. ... Biotechnology & Medical Research Raymond James Initiates Faeth Therapeutics at Outperform Published on 07/31/2026…

EWTXFTHYMAT

From the 4Search news index, newest first.

In the news

10mentions in 30 days
10with it in the headline
Positivesentiment

Mentioned with

Faeth Therapeutics, Inc.8Greater Houston Area8Healthcare System Knox8J-Star Holding Co., Ltd8Largest Federal Cloud Eos Energy Enterprises8U.S. Drone Manufacturing Initiative8Host Technology Webinar7Compensation Committee3

People in the coverage

Anand Parikh10Lewis Cantley10Oliver Maddocks10Greg Hannon9Karen Vousden9Scott Lowe9

Themes

Healthcare8Biotechnology7SEC Filings6EPS4Consensus3Ratings35635(C)(4)2Analyst Recommendations2

Most coverage from

  1. marketscreener.com9
  2. nasdaq.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance